These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15974912)

  • 1. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
    Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
    Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.
    Zaltzman R; Alexandrovich A; Trembovler V; Shohami E; Gozes I
    Peptides; 2005 Aug; 26(8):1520-7. PubMed ID: 16042992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent neuroprotective protein: from gene to drug candidate.
    Gozes I
    Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis.
    Romano J; Beni-Adani L; Nissenbaum OL; Brenneman DE; Shohami E; Gozes I
    J Mol Neurosci; 2002; 18(1-2):37-45. PubMed ID: 11931348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
    J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
    Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function.
    Quintana FJ; Zaltzman R; Fernandez-Montesinos R; Herrera JL; Gozes I; Cohen IR; Pozo D
    Ann N Y Acad Sci; 2006 Jul; 1070():500-6. PubMed ID: 16888216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Specific ADNP/NAP (Davunetide) Regulation of Cocaine-Induced Plasticity.
    Toren Y; Ziv Y; Sragovich S; McKinney RA; Barak S; Shazman S; Gozes I
    J Mol Neurosci; 2024 Sep; 74(3):76. PubMed ID: 39251453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I
    Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
    Gozes I; Divinski I
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain injury-dependent expression of activity-dependent neuroprotective protein.
    Zaltzman R; Alexandrovich A; Beni SM; Trembovler V; Shohami E; Gozes I
    J Mol Neurosci; 2004; 24(2):181-7. PubMed ID: 15456931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
    Gozes I
    Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).
    Gozes I; Morimoto BH; Tiong J; Fox A; Sutherland K; Dangoor D; Holser-Cochav M; Vered K; Newton P; Aisen PS; Matsuoka Y; van Dyck CH; Thal L
    CNS Drug Rev; 2005; 11(4):353-68. PubMed ID: 16614735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
    Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
    Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.
    Beni-Adani L; Gozes I; Cohen Y; Assaf Y; Steingart RA; Brenneman DE; Eizenberg O; Trembolver V; Shohami E
    J Pharmacol Exp Ther; 2001 Jan; 296(1):57-63. PubMed ID: 11123362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.
    Karmon G; Sragovich S; Hacohen-Kleiman G; Ben-Horin-Hazak I; Kasparek P; Schuster B; Sedlacek R; Pasmanik-Chor M; Theotokis P; Touloumi O; Zoidou S; Huang L; Wu PY; Shi R; Kapitansky O; Lobyntseva A; Giladi E; Shapira G; Shomron N; Bereswill S; Heimesaat MM; Grigoriadis N; McKinney RA; Rubinstein M; Gozes I
    Biol Psychiatry; 2022 Jul; 92(1):81-95. PubMed ID: 34865853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.
    Braitch M; Kawabe K; Nyirenda M; Gilles LJ; Robins RA; Gran B; Murphy S; Showe L; Constantinescu CS
    Neuroimmunomodulation; 2010; 17(2):120-5. PubMed ID: 19923857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.